Assessment and stratification of cardiovascular disease risk in people diagnosed with breast cancer: A scoping review
Open Access
- 25 February 2025
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 135, 102903
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (APP1153420, APP 1176651)
- University of Queensland
- National Heart Foundation of Australia (ID 105508)
This publication has 73 references indexed in Scilit:
- Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patientsBreast Cancer Research and Treatment, 2024
- Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast CancerJAMA Network Open, 2023
- Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapiesWiener klinische Wochenschrift, 2022
- Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk toolsBreast Cancer Research and Treatment, 2021
- Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative reviewBreast Cancer Research and Treatment, 2021
- Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)European Journal of Heart Failure, 2020
- Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology SocietyEuropean Journal of Heart Failure, 2020
- The risk of cardiovascular disease following breast cancer by Framingham risk scoreBreast Cancer Research and Treatment, 2018
- A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht scoreInternal and Emergency Medicine, 2012
- The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclinesBreast Cancer Research and Treatment, 2007